Study confirms link between SABA inhalers and asthma exacerbations
High SABA inhaler use was associated with around twice the number of exacerbations, the SABINA study found
Read More
Tag: ICL
Researchers to test potential COVID-19 treatment in UK
TRV027 targets cell pathways thought to be major drivers of severe illness in COVID-19
Read More
Kawasaki-like syndrome linked to coronavirus is new condition
The new condition is called Paediatric Inflammatory Multisystem Syndrome Temporally associated with SARS-CoV-2 (PIMS-TS)
Read More
EU lockdowns saved more than 3m lives, research indicates
The research also suggests that coronavirus was more infectious than previously estimated
Read More
Gov’t streams £84m into UK COVID-19 vaccines research
The move comes as Oxford Uni and AZ sign a global licensing deal for their vaccine candidate
Read More
Imperial College London partners with NHS Trust to make PPE
More than 6,000 visors have already been delivered to Charing Cross Hospital
Read More
UK COVID-19 vaccine to begin human testing
The government has given £42.5 million to support vaccine projects at Oxford University and Imperial College London
Read More
Survey reveals ‘critical deficiencies’ in NHS record-keeping
Policymakers must identify fragmented systems and promote better data sharing, study authours say
Read More
CEPI, Imperial College partner for emerging diseases vaccines
The Coalition for Epidemic Preparedness Innovations (CEPI) and Imperial College London have announced a partnership to develop a self-amplifying RNA vaccine platform (saRNA), enabling tailored vaccine production against multiple viral pathogens.
Read More
Heptares, ICL sign gastrointestinal R&D pact
Heptares Therapeutics, the UK-headquartered wholly-owned subsidiary of Japan’s Sosei Group, has formed a new drug research and development pact with Imperial College London focused on gastrointestinal disease.
Read More
AZ and ICL link to research respiratory diseases
AstraZeneca and Imperial College London have announced plans to work together on investigating the scientific mechanisms and underlying drivers of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD).
Read More
- Tozorakimab shows significant benefit in two major COPD trials
- Daratumumab becomes first oncology injectable approved for patient administration
- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
